Factors associated with depressive symptoms in Japanese women with rheumatoid arthritis

Hamasaki, Miwa; Origuchi, Tomoki; Matsuura, Eiji

doi:10.1093/rap/rkac006

Cited by 3 publications

(2 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to McQuillan et al ( 2022 ), RA functional disability is more strongly associated with depression in males than in females. Depressive symptoms in female patients appear to be more closely related to poor sleep quality or family pressure (Hughes et al, 2021 ; Hamasaki et al, 2022 ).…”

Section: What Causes Depression In Ra Patients?mentioning

confidence: 99%

Research progress on rheumatoid arthritis-associated depression

Liu

Wang

Shi

et al. 2023

Front. Behav. Neurosci.

View full text Add to dashboard Cite

Depression is an independent mood disorder and one of the most common comorbidities of rheumatoid arthritis (RA). Growing evidence suggests that there is two-way regulation between RA and depression, resulting in a vicious cycle of RA, depression, poor outcomes, and disease burden. The rising prevalence of RA-associated depression warrants a re-examination of the relationships between them. Here we provide an overview of the etiology and pathological mechanisms of RA-associated depression, and recent advances in treatment with biologics, which will facilitate the development of new and effective prevention and treatment strategies.

show abstract

Section: What Causes Depression In Ra Patients?mentioning

confidence: 99%

Research progress on rheumatoid arthritis-associated depression

Liu

Wang

Shi

et al. 2023

Front. Behav. Neurosci.

View full text Add to dashboard Cite

show abstract

“… 12 Factors such as difficulties in daily life, self-confidence in coping with stress, and expected health status are associated with depression in rheumatoid arthritis (RA) patients. 13 In another study, there has been reported a relationship between poor sleep quality and anxiety, depression, self-efficacy, and stigma in RA patients. 14 Here, sleep disturbance was found to be positively correlated with age, pain, disease activity, depression, anxiety, and stigma, while self-efficacy was negatively correlated with sleep disturbance.…”

Section: Introductionmentioning

confidence: 96%

The Anxiety and Depression in Rheumatoid Arthritis Patients Treating with Disease-Modifying Anti-Rheumatic Drugs during the COVID-19 Pandemic

Sargın¹,

Baygin²,

Şentürk³

2022

MJR

View full text Add to dashboard Cite

Objective: Anxiety and depression are associated with the risk of illness, presence of physical symptoms, and poor health in the COVID-19 epidemic. Our aim is to assess the severity of anxiety and depression in rheumatoid arthritis (RA) patients treated with disease-modifying anti-rheumatic drugs during the COVID-19 pandemic. Material and methods: The study is a longitudinal, hospital-based survey study including 102 RA patients receiving disease-modifying anti-rheumatic drugs with a mean of 55,2±11,9 years. Demographic data, educational status, marital status, employment status, economic status, patients with psychiatric disorders (with the use of prescribed medication for treatment), and medications were recorded. The severity of depression and anxiety were evaluated with the Beck Anxiety and Depression Inventory at the first and second visit of the follow-up during the pandemic period. Results: The mean Beck depression inventory score was found to be higher in the conventional synthetic DMARDs group than in biological DMARDs (12,1±8,2 vs 11,6±9,2, p=0,554). 46 (65,7%) had mild to severe anxiety symptoms in RA patients treated with conventional synthetic DMARDs, on the first visit. There was no significant difference in anxiety and depression status between the first and second visits. The difference in anxiety and depression symptoms between RA patients receiving conventional synthetic and biological DMARDs does not attain statistical significance. Also, no significant differences were found in anxiety and depression scores in the comparisons for gender, education, marital, working, and economic status. Conclusions: The severity of depression and anxiety were higher in RA patients receiving conventional synthetic DMARDs and biological DMARDs during the COVID-19 pandemic. Also, RA patients are likely to experience anxiety and depression during the period of the pandemic.

show abstract

Sleep quality, anxiety, depression, and quality of life in rheumatoid arthritis patients and impact of disease activity

Abdelrahman,

Shaddad,

Khaleel

et al. 2024

Egypt Rheumatol Rehabil

View full text Add to dashboard Cite

Background Rheumatoid arthritis (RA) is an autoimmune lifelong disease. Systemic manifestations represent a significant aspect of the disease burden. This study aimed to assess sleep quality and psychosocial aspects among RA patients and the impact of disease duration and activity. Results The mean age for included RA patients was 50.00 ± 9.37 years. The median disease duration was 9.50 (Interquartile range (IQR)=5–15) years and 90% of patients were females. Disease activity score 28 was 4.65 ± 1.66. Anxiety and depression were significantly higher among RA participants. Regarding sleep quality assessment, RA group had significantly higher levels of insomnia than the control group (Insomnia Severity Index median (IQR) was 4.5 (0–15) versus 1 (0–3); p value = 0.013) and daytime sleepiness (Epworth Sleepiness Scale median (IQR) was 4 (1–11.25) versus 1 (0–3); p value = 0.002). RA patients showed significantly higher values of Pittsburgh Sleep Quality Index components as well as the global score indicating poor sleep quality. The 36-item short-form health survey domains, representing physical and mental health, were significantly lower among RA cases versus control subjects. Higher disease activity was positively correlated with anxiety, depression, insomnia, sleep quality, sleep efficiency, and daytime dysfunction, while negatively correlated with all domains of the 36-item short-form health survey. Conclusions RA patients have increased anxiety and depression levels in addition to poor sleep quality. High disease activity is linked to increased anxiety and depression levels, impaired quality of life, and poor sleep quality.

show abstract

Factors associated with depressive symptoms in Japanese women with rheumatoid arthritis

Cited by 3 publications

References 29 publications

Research progress on rheumatoid arthritis-associated depression

Research progress on rheumatoid arthritis-associated depression

The Anxiety and Depression in Rheumatoid Arthritis Patients Treating with Disease-Modifying Anti-Rheumatic Drugs during the COVID-19 Pandemic

Sleep quality, anxiety, depression, and quality of life in rheumatoid arthritis patients and impact of disease activity

Contact Info

Product

Resources

About